Global Nanotechnology-based Drug Delivery Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06255580

Publication Date:

June 23, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Nanotechnology-based Drug Delivery market size is predicted to grow from US$ 121060 million in 2025 to US$ 244740 million in 2031; it is expected to grow at a CAGR of 12.4% from 2025 to 2031.
United States market for Nanotechnology-based Drug Delivery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Nanotechnology-based Drug Delivery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Nanotechnology-based Drug Delivery is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Nanotechnology-based Drug Delivery players cover AbbVie Inc., BlueWillow Biologics Inc., Camurus AB, Celgene, lnc., Cristal Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淣anotechnology-based Drug Delivery Industry Forecast鈥� looks at past sales and reviews total world Nanotechnology-based Drug Delivery sales in 2024, providing a comprehensive analysis by region and market sector of projected Nanotechnology-based Drug Delivery sales for 2025 through 2031. With Nanotechnology-based Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nanotechnology-based Drug Delivery industry.
This Insight Report provides a comprehensive analysis of the global Nanotechnology-based Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nanotechnology-based Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Nanotechnology-based Drug Delivery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nanotechnology-based Drug Delivery and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nanotechnology-based Drug Delivery.
This report presents a comprehensive overview, market shares, and growth opportunities of Nanotechnology-based Drug Delivery market by product type, application, key players and key regions and countries.
Segmentation by Type:
Nanocrystals
Nanoparticles
Liposomes
Micelles
Others
Segmentation by Application:
Hospital
Research Institute
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie Inc.
BlueWillow Biologics Inc.
Camurus AB
Celgene, lnc.
Cristal Therapeutics
EyePoint Pharmaceuticals
Johnson and Johnson

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nanotechnology-based Drug Delivery Market Size (2020-2031)
2.1.2 Nanotechnology-based Drug Delivery Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nanotechnology-based Drug Delivery by Country/Region (2020, 2024 & 2031)
2.2 Nanotechnology-based Drug Delivery Segment by Type
2.2.1 Nanocrystals
2.2.2 Nanoparticles
2.2.3 Liposomes
2.2.4 Micelles
2.2.5 Others
2.3 Nanotechnology-based Drug Delivery Market Size by Type
2.3.1 Nanotechnology-based Drug Delivery Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nanotechnology-based Drug Delivery Market Size Market Share by Type (2020-2025)
2.4 Nanotechnology-based Drug Delivery Segment by Application
2.4.1 Hospital
2.4.2 Research Institute
2.4.3 Others
2.5 Nanotechnology-based Drug Delivery Market Size by Application
2.5.1 Nanotechnology-based Drug Delivery Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nanotechnology-based Drug Delivery Market Size Market Share by Application (2020-2025)
3 Nanotechnology-based Drug Delivery Market Size by Player
3.1 Nanotechnology-based Drug Delivery Market Size Market Share by Player
3.1.1 Global Nanotechnology-based Drug Delivery Revenue by Player (2020-2025)
3.1.2 Global Nanotechnology-based Drug Delivery Revenue Market Share by Player (2020-2025)
3.2 Global Nanotechnology-based Drug Delivery Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nanotechnology-based Drug Delivery by Region
4.1 Nanotechnology-based Drug Delivery Market Size by Region (2020-2025)
4.2 Global Nanotechnology-based Drug Delivery Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nanotechnology-based Drug Delivery Market Size Growth (2020-2025)
4.4 APAC Nanotechnology-based Drug Delivery Market Size Growth (2020-2025)
4.5 Europe Nanotechnology-based Drug Delivery Market Size Growth (2020-2025)
4.6 Middle East & Africa Nanotechnology-based Drug Delivery Market Size Growth (2020-2025)
5 Americas
5.1 Americas Nanotechnology-based Drug Delivery Market Size by Country (2020-2025)
5.2 Americas Nanotechnology-based Drug Delivery Market Size by Type (2020-2025)
5.3 Americas Nanotechnology-based Drug Delivery Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nanotechnology-based Drug Delivery Market Size by Region (2020-2025)
6.2 APAC Nanotechnology-based Drug Delivery Market Size by Type (2020-2025)
6.3 APAC Nanotechnology-based Drug Delivery Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nanotechnology-based Drug Delivery Market Size by Country (2020-2025)
7.2 Europe Nanotechnology-based Drug Delivery Market Size by Type (2020-2025)
7.3 Europe Nanotechnology-based Drug Delivery Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nanotechnology-based Drug Delivery by Region (2020-2025)
8.2 Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Type (2020-2025)
8.3 Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nanotechnology-based Drug Delivery Market Forecast
10.1 Global Nanotechnology-based Drug Delivery Forecast by Region (2026-2031)
10.1.1 Global Nanotechnology-based Drug Delivery Forecast by Region (2026-2031)
10.1.2 Americas Nanotechnology-based Drug Delivery Forecast
10.1.3 APAC Nanotechnology-based Drug Delivery Forecast
10.1.4 Europe Nanotechnology-based Drug Delivery Forecast
10.1.5 Middle East & Africa Nanotechnology-based Drug Delivery Forecast
10.2 Americas Nanotechnology-based Drug Delivery Forecast by Country (2026-2031)
10.2.1 United States Market Nanotechnology-based Drug Delivery Forecast
10.2.2 Canada Market Nanotechnology-based Drug Delivery Forecast
10.2.3 Mexico Market Nanotechnology-based Drug Delivery Forecast
10.2.4 Brazil Market Nanotechnology-based Drug Delivery Forecast
10.3 APAC Nanotechnology-based Drug Delivery Forecast by Region (2026-2031)
10.3.1 China Nanotechnology-based Drug Delivery Market Forecast
10.3.2 Japan Market Nanotechnology-based Drug Delivery Forecast
10.3.3 Korea Market Nanotechnology-based Drug Delivery Forecast
10.3.4 Southeast Asia Market Nanotechnology-based Drug Delivery Forecast
10.3.5 India Market Nanotechnology-based Drug Delivery Forecast
10.3.6 Australia Market Nanotechnology-based Drug Delivery Forecast
10.4 Europe Nanotechnology-based Drug Delivery Forecast by Country (2026-2031)
10.4.1 Germany Market Nanotechnology-based Drug Delivery Forecast
10.4.2 France Market Nanotechnology-based Drug Delivery Forecast
10.4.3 UK Market Nanotechnology-based Drug Delivery Forecast
10.4.4 Italy Market Nanotechnology-based Drug Delivery Forecast
10.4.5 Russia Market Nanotechnology-based Drug Delivery Forecast
10.5 Middle East & Africa Nanotechnology-based Drug Delivery Forecast by Region (2026-2031)
10.5.1 Egypt Market Nanotechnology-based Drug Delivery Forecast
10.5.2 South Africa Market Nanotechnology-based Drug Delivery Forecast
10.5.3 Israel Market Nanotechnology-based Drug Delivery Forecast
10.5.4 Turkey Market Nanotechnology-based Drug Delivery Forecast
10.6 Global Nanotechnology-based Drug Delivery Forecast by Type (2026-2031)
10.7 Global Nanotechnology-based Drug Delivery Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Nanotechnology-based Drug Delivery Forecast
11 Key Players Analysis
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Information
11.1.2 AbbVie Inc. Nanotechnology-based Drug Delivery Product Offered
11.1.3 AbbVie Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 AbbVie Inc. Main Business Overview
11.1.5 AbbVie Inc. Latest Developments
11.2 BlueWillow Biologics Inc.
11.2.1 BlueWillow Biologics Inc. Company Information
11.2.2 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Product Offered
11.2.3 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 BlueWillow Biologics Inc. Main Business Overview
11.2.5 BlueWillow Biologics Inc. Latest Developments
11.3 Camurus AB
11.3.1 Camurus AB Company Information
11.3.2 Camurus AB Nanotechnology-based Drug Delivery Product Offered
11.3.3 Camurus AB Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Camurus AB Main Business Overview
11.3.5 Camurus AB Latest Developments
11.4 Celgene, lnc.
11.4.1 Celgene, lnc. Company Information
11.4.2 Celgene, lnc. Nanotechnology-based Drug Delivery Product Offered
11.4.3 Celgene, lnc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Celgene, lnc. Main Business Overview
11.4.5 Celgene, lnc. Latest Developments
11.5 Cristal Therapeutics
11.5.1 Cristal Therapeutics Company Information
11.5.2 Cristal Therapeutics Nanotechnology-based Drug Delivery Product Offered
11.5.3 Cristal Therapeutics Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Cristal Therapeutics Main Business Overview
11.5.5 Cristal Therapeutics Latest Developments
11.6 EyePoint Pharmaceuticals
11.6.1 EyePoint Pharmaceuticals Company Information
11.6.2 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Product Offered
11.6.3 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 EyePoint Pharmaceuticals Main Business Overview
11.6.5 EyePoint Pharmaceuticals Latest Developments
11.7 Johnson and Johnson
11.7.1 Johnson and Johnson Company Information
11.7.2 Johnson and Johnson Nanotechnology-based Drug Delivery Product Offered
11.7.3 Johnson and Johnson Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Johnson and Johnson Main Business Overview
11.7.5 Johnson and Johnson Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂